Amineptine

DB04836ApprovedIllicitWithdrawnSmall molecule

The Food and Drug Administration suspended the marketing authorisation for Survector in 1999 and France withdrew it from the market, however several developing countries continued to produce it up until...

Chemical structure of Amineptine
Mechanism
Curator reviewed
Primary indication
For the treatment of depression.Curator reviewed
Formula / weight
C22H27NO2 · 337.463 g/mol (avg)

Resolves to

Compound
UNII27T1I13L6GCAS57574-09-1ChEMBLCHEMBL418995ChEBI32499PubChem34869KEGGD07335
Clinical / RWD
RxNorm17698ATCN06AA19
Structure
InChIKeyONNOFKFOZAJDHT-UHFFFAOYSA-NSMILESOC(=O)CCCCCCNC1C2=CC=CC=C2CCC2=CC=CC=C12
Targets
Q01959SLC6A3P23975SLC6A2P31645SLC6A4

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,688Drug interactionsStructured to mechanism, not free text
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 16 drug categories
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Amineptine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In